Bulbospinal serotonergic activity during changes in thyroid status

Citation
Wn. Henley et al., Bulbospinal serotonergic activity during changes in thyroid status, CAN J PHYSL, 76(12), 1998, pp. 1120-1131
Citations number
34
Categorie Soggetti
Pharmacology & Toxicology
Journal title
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
ISSN journal
00084212 → ACNP
Volume
76
Issue
12
Year of publication
1998
Pages
1120 - 1131
Database
ISI
SICI code
0008-4212(199812)76:12<1120:BSADCI>2.0.ZU;2-V
Abstract
A three-part study explored the basis for an interaction between changes in thyroid status and bulbospinal serotonin (5HT) metabolism. In experiment 1 , three well-characterized models of primary hypothyroidism were all accomp anied by significant increases in 5HT metabolism. In experiment 2, circulat ing thyroid hormone levels were experimentally varied from very low methima zole (Meth) treatment to very high (T-3 implants: 2.5, 5.0, or 7.5 mg triio dothyronine). As ia experiment 1, Meth led to elevated 5HT. Hyperthyroidism was accompanied by significant reductions in 5HT, while urinary norepineph rine excretion paralleled 5HT. In experiment 3, rats were subjected to Meth either 2 weeks before or after induction of diabetes with streptozotocin ( Stz). Meth prevented Stz-associated reductions in 5HT and attenuated develo pment of hyperphagia. Meth could not reverse established Stz-associated red uction in 5HT or hyperphagia, although both were slightly attenuated. Thus, although the first two experiments argue for a simple inverse relationship between circulating thyroid hormone levels and 5HT in the brain, experimen t 3 demonstrated that Stz-associated decrements in 5HT could not be reverse d by subsequent lowering of circulating thyroid hormone. Nor did accompanyi ng measurements indicate that glycemic status or circulating levels of lept in were important predictors of 5HT. Thus the interaction between thyroid h ormones and 5HT is both more subtle and more complex than previously though t.